Beijing Friendship Hospital
Beijing, Beijing Municipality, 100050, China
Location status: Recruiting
NCT Number: NCT06394089
A single-center, prospective cohort trial aims to provide stronger evidence regarding the impact of degenerative spondylolisthesis on the clinical outcome of unilateral biportal endoscopy for lumbar spinal stenosis
Interested in participating?
Request Info50 year–80 year
All sexes
Observational
Beijing, Beijing Municipality, 100050, China
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: From enrollment to the end of follow-up at 2 year
0-100%, the higher the score, the more severe the lumbar spine dysfunction
Time frame: From enrollment to the end of follow-up at 2 year
Progression of lumbar spondylolisthesis, assessed by postoperative lumbar radiography; (2) Measurement of sagittal translation, segmental angulation, and posterior opening based on postoperative standing flexion-extension radiographs
Time frame: From enrollment to the end of follow-up at 2 year
Assessment of bone resection area and preservation rate of the facet joint using postoperative computed tomography (CT) scans
Time frame: From enrollment to the end of follow-up at 2 year
Calculation of the enlargement ratio of the dural sac based on postoperative magnetic resonance imaging (MRI)
Time frame: From enrollment to the end of follow-up at 2 year
Any adverse events will be recorded to evaluate the safety of decompression using UBE for LSS with or without DS
Time frame: From enrollment to the end of follow-up at 2 year
0-10, the higher the score, the more severe the pain
Time frame: From enrollment to the end of follow-up at 2 year
0-10, the higher the score, the more severe the pain
Time frame: Immediately after the surgery
Time to perform the operation
Time frame: Immediately after the surgery
B、 Blood loss during the surgery
Time frame: Immediately after the discharge
Number of days in hospital after operation
Time frame: From enrollment to the end of follow-up at 2 year
0-29, the higher the score, the better the lumbar spine function
Time frame: From enrollment to the end of follow-up at 2 year
According to satisfaction, it is divided into four levels: excellent, good, acceptable, and poorexcellent, good, fair, and poor
Time frame: From enrollment to the end of follow-up at 2 year
Improvement ratio= (preoperative VAS-postoperative VAS/preoperative VAS, ranging from 0-100%, the higher the score, the better the improment of symptoms
Time frame: From enrollment to the end of follow-up at 2 year
Improvement ratio= (preoperative VAS-postoperative VAS/preoperative VAS, ranging from 0-100%, the higher the score, the better the improment of symptoms
Time frame: From enrollment to the end of follow-up at 2 year
Improvement ratio= (postoperative JOA-preoperative JOA/preoperative VAS, ranging from 0-100%, the higher the score, the better the improment of spinal function
Time frame: From enrollment to the end of follow-up at 2 year
Improvement ratio= (preoperative ODI-postoperative ODI)/preoperative ODI, ranging from 0-100%, the higher the score, the better the improment of symptoms
Time frame: From enrollment to 3 days after surgery
White blood cell count of venous blood
Time frame: From enrollment to 3 days after surgery
The proportion of neutrophils relative to the total white blood cell count
Time frame: From enrollment to 3 days after surgery
The level of C-reactive protein in blood
Time frame: From enrollment to 3 days after surgery
The level of creatine kinase in blood
Time frame: From enrollment to 3 days after surgery
The level of Lactate dehydrogenase in blood
Time frame: From enrollment to 3 days after surgery
The level of myoglobin in blood
Contact information is provided by the study sponsor or research team.
Beijing Friendship Hospital
Other
Effect of Degenerative Spondylolisthesis on the Clinical Outcome of Unilateral Biportal Endoscopy for Lumbar Spinal Stenosis: a Single-center, Prospective Cohort Trial Protocol
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05029726
Bone Diseases, Cysts
Chicago, Illinois, United States
View Trial DetailsNCT07644507
Bone Diseases, Degenerative Lumbar Spine Diseases
Wroclaw, Poland
View Trial DetailsNCT07410871
Bone Diseases, Degenerative Spondylolisthesis
Kafr ash Shaykh, Kafrelsheikh, Egypt
View Trial DetailsNCT03570801
Bone Diseases, Degenerative Spondylolisthesis
Scottsdale, Arizona, United States
View Trial Details